Comparative study of symptom improvement effect of vonoprazan and esomeprazole in patients with reflux esophagitis.
Not Applicable
Recruiting
- Conditions
- Reflex esophagitis
- Registration Number
- JPRN-UMIN000028962
- Lead Sponsor
- Ikoma Gastorenteroproctorogy Clinic
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.The patients with warning signs such as vomiting, gastrointestinal bleeding and sudden weight loss. 2.The patients with confirmed or suspected malignant diseases. 3.The patients with a history of gastrointestinal resection of vagotomy. 4.The patients with a history of irritable bowel syndrome. 5.The patients whose participation in this study would be contraindicated due to complications such as serious heaptic, renal or heart disease. 6.The Pregnant patients or possibly pregnant patients. 7.The patients prohibited the participant of this study by their attending physicians. 8.The patients who took esomeprazole or vonoprazan within 4 weeks.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The change of total score evaluated using FSSG
- Secondary Outcome Measures
Name Time Method